Adthera Bio Limited

Adthera Bio Ltd, based in Birmingham, UK, is a small, active company founded two years ago. With three employees and £2,652,376 in assets, it operates from a real address and is managed by two directors and one owner. The company regularly imports plastics and plastic products, with the last import operation made in March 2024.

The company’s website showcases Adthera Bio as a “CDMO for Cell Gene Therapy,” offering process development, manufacturing, and regulatory compliance services. It appears to be a contract development and manufacturing organization (CDMO) focused on biotechnology, specifically cell and gene therapy. The site highlights its capabilities and experience, and encourages visitors to connect with the team. There's no obvious e-commerce element; instead, it's a platform for showcasing expertise and attracting clients.

Financially, Adthera Bio Ltd shows a mixed picture. While cash at hand remains strong at £2,400,000, net assets are in the negative at -£1,000,000. This suggests the company is burning through cash or has significant liabilities. Bank borrowings are relatively low at £29,000, and creditors are substantial at £4,400,000. The company’s small size (meeting two of three criteria for turnover under £10.2m, assets under £5.1m, and fewer than 50 employees) allows for flexibility, but the negative equity is a concern. No auditor is mentioned, which is typical for small companies.

Overall, Adthera Bio Ltd seems to be a promising biotech CDMO, but its financial data indicates it’s facing challenges. The company’s focus on a specialized field like cell and gene therapy could be a strength, but it also requires significant investment and expertise. The negative equity suggests the company may be reliant on continued funding or needs to improve its profitability to avoid burning through its cash reserves.

Registered in England/Wales under the registration number 14372438, with a registered address at B16 8PE, England, Birmingham, Lyndon House, 12th Floor, 62 Hagley Road.

WARNING:The numbers have been rounded for simplicity and may be inaccurate.Please, refer to the latest financial report for verification.